Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Solution Preparation in Injectable Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Solution Preparation in Injectable Manufacturing – V 2.0

Standard Operating Procedure for Solution Preparation in Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/031/2025
Supersedes SOP/SIM/031/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the step-by-step procedure for the preparation of sterile injectable solutions ensuring uniformity, compliance with specifications, and regulatory requirements (GMP, WHO, ICH).

2. Scope

This SOP applies to the preparation of drug solutions in the

manufacturing area for intravenous, intramuscular, subcutaneous, and other parenteral dosage forms in sterile injectable facilities.

3. Responsibilities

  • Manufacturing Operator: Execute solution preparation activities as per batch manufacturing record.
  • Production Supervisor: Supervise and verify all steps during solution preparation.
  • QA Officer: Perform in-process checks and review records.

4. Accountability

The Head – Production shall be accountable for implementation and compliance of this SOP.

See also  Quality Assurance: SOP for Documentation of Change Control Processes - V 2.0

5. Procedure

5.1 Pre-Operation Checks

  1. Verify cleanliness status of the preparation room, equipment (vessels, transfer lines), and entry logs.
  2. Ensure availability and calibration status of instruments such as pH meter, thermometer, and conductivity meter.
  3. Review previous batch reconciliation and clearance documentation from QA.

5.2 Material Verification

  1. Collect dispensed raw materials and excipients along with CoA, label, and dispensing log.
  2. Verify material identity, quantity, status label, and batch number before charging.
  3. Record in Annexure-1: Material Verification Sheet.

5.3 Charging Procedure

  1. Start recirculation of WFI to sanitize the solution preparation vessel.
  2. Add pre-measured quantity of WFI into the preparation vessel and adjust temperature if required.
  3. Charge active and excipient materials one by one under LAF using a closed transfer system.
  4. For temperature-sensitive APIs, ensure controlled cooling during charging.

5.4 Mixing and Dissolution

  1. Start mechanical agitation at defined RPM as per BMR.
  2. Continue agitation until complete dissolution or dispersion.
  3. Check for visual clarity, pH, and specific gravity as required.
  4. Record readings in Annexure-2: In-Process Check Log.

5.5 pH and Volume Adjustment

  1. Measure pH using a calibrated pH meter; adjust with 0.1N acid or alkali as per specification.
  2. Make up the final volume using WFI under mixing conditions.
  3. Confirm batch yield calculation and reconciliation.
See also  Sterile Injectable Manufacturing: SOP for Documenting Cleaning Validation Reports - V 2.0

5.6 Filtration

  1. Use pre-sterilized 0.22 µm filter cartridges for final solution filtration.
  2. Maintain sterile conditions throughout the filtration process.
  3. Record filter integrity test results before and after filtration in Annexure-3.

5.7 Post-Filtration Sampling

  1. Draw samples for QC testing (Assay, pH, Sterility, Endotoxin).
  2. Send sample along with sample request form and fill in Annexure-4: Sampling Record.

5.8 Documentation and Line Clearance

  1. Fill solution preparation log with details including time, batch no., temperature, operator initials.
  2. Submit completed batch record to QA for review and line clearance.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • BMR: Batch Manufacturing Record
  • WFI: Water for Injection
  • LAF: Laminar Air Flow
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Material Verification Sheet – Annexure-1
  2. In-Process Check Log – Annexure-2
  3. Filter Integrity Test Log – Annexure-3
  4. Sampling Record – Annexure-4

8. References

  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO TRS 986 – Sterile Pharmaceutical Production
  • ICH Q8 – Pharmaceutical Development
See also  Sterile Injection Manufacturing: SOP for Use of Automated Labeling Machines in Packing Lines - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Material Verification Sheet

Material Qty Batch No. Status Checked By
Sodium Chloride 50 g SC2401 Approved Meena Patil

Annexure-2: In-Process Check Log

Parameter Specification Observed Time Initials
pH 4.5 – 5.5 5.1 10:30 AK

Annexure-3: Filter Integrity Test Log

Date Filter ID Bubble Point Status Checked By
18/06/2025 FLTR1025 54 psi Pass Sunil Rao

Annexure-4: Sampling Record

Sample Type Quantity Container No. Sent By Time
Assay + pH 25 ml S-10 Deepa Sharma 11:15

Revision History

Revision Date Revision No. Details Reason Approved By
05/04/2022 1.0 Initial Release New SOP QA Head
18/06/2025 2.0 Filter test and in-process checks enhanced Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: BA-BE Studies: SOP for Selectivity and Sensitivity Evaluation – V 2.0
Next Post: Aerosol: SOP for Managing Calibration Schedules for Manufacturing Instruments – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version